Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2011

01-02-2011

Consanguinity Rate and Delay in Diagnosis in Turkish Patients with Combined Immunodeficiencies: a Single-Center Study

Authors: Elif Azarsiz, Nesrin Gulez, Neslihan Edeer Karaca, Guzide Aksu, Necil Kutukculer

Published in: Journal of Clinical Immunology | Issue 1/2011

Login to get access

Abstract

Combined immunodeficiency diseases comprise a group of disorders with different molecular basis. Clinical and immunological phenotypes for each group are extremely heterogenous. The frequency of combined immunodeficiencies may vary in different countries. The most frequent forms of combined immunodeficiency show inherited defects in development of T and/or B lymphocytes. These defects are classified according to immunologic phenotype and are categorized into T−B+ or T−B− including forms with or without natural killer lymphocytes. We report here twenty-three patients (female/male: 12/11) with combined immunodeficiency showing different immunological and clinical phenotypes, majority of whom were admitted because of severe upper and lower respiratory tract infections. Mean age of the study group, mean age at onset of the symptoms, and diagnosis were 47.5 ± 42.2, 11.2 ± 17.3, and 19.5 ± 23.8 months, respectively. There was nearly 8 months time delay between beginning of symptoms and diagnosis. Within the combined immunodeficiency phenotypes, T−B−NK+ category was the most frequent phenotype. Consanguinity was positive in 73.9% (n = 17) of patients while it was about 80.0% (n = 8) in deceased ten children. Bone marrow or umblical cord stem cell transplantation was applied to 11 of them. Three patients deceased after transplantation and seven patients deceased without transplantation. Twelve patients are being followed by prophylactic treatment. In conclusion; combined immunodeficiencies are frequent in our country because of high rate of consanguinity. T−B− combined immunodeficiencies are more often observed, and infants presenting severe infections beginning in the first 3 months of life have to be examined for combined immunodeficiencies. Shortening of time delay in diagnosis will increase success of life-saving treatment.
Literature
1.
go back to reference Notarangelo LD. Primary immunodeficiencies. The Journal of Allergy and Clinical Immunology. 2010;125:S182–94.CrossRefPubMed Notarangelo LD. Primary immunodeficiencies. The Journal of Allergy and Clinical Immunology. 2010;125:S182–94.CrossRefPubMed
2.
go back to reference Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, et al. Primary immunodeficiencies: 2009 update. The Journal of Allergy and Clinical Immunology. 2009;124:1161–78.CrossRefPubMed Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, et al. Primary immunodeficiencies: 2009 update. The Journal of Allergy and Clinical Immunology. 2009;124:1161–78.CrossRefPubMed
3.
go back to reference Van der Burg M, Van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH, et al. A new type of radiosensitive T−B−NK+ severe combined immunodeficiency caused by a LIG4 mutation. Journal of Clinical Investigation. 2006;116:137–45.CrossRefPubMed Van der Burg M, Van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH, et al. A new type of radiosensitive T−B−NK+ severe combined immunodeficiency caused by a LIG4 mutation. Journal of Clinical Investigation. 2006;116:137–45.CrossRefPubMed
4.
go back to reference Van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, Morotomi-Yano K, et al. A DNA-PKcs mutation in a radiosensitive T−B− SCID patient inhibits Artemis activation and nonhomologous end-joining. Journal of Clinical Investigation. 2009;119:91–8.PubMed Van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, Morotomi-Yano K, et al. A DNA-PKcs mutation in a radiosensitive T−B− SCID patient inhibits Artemis activation and nonhomologous end-joining. Journal of Clinical Investigation. 2009;119:91–8.PubMed
5.
go back to reference Buck D, Malivert L, de Chasseval R, Barraud A, Fondanèche MC, Sanal O, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell. 2006;124(2):287–99.CrossRefPubMed Buck D, Malivert L, de Chasseval R, Barraud A, Fondanèche MC, Sanal O, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell. 2006;124(2):287–99.CrossRefPubMed
6.
go back to reference Pannicke U, Hönig M, Hess I, Friesen C, Holzmann K, Rump EM, et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nature Genetics. 2009;41:101–5.CrossRefPubMed Pannicke U, Hönig M, Hess I, Friesen C, Holzmann K, Rump EM, et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nature Genetics. 2009;41:101–5.CrossRefPubMed
7.
go back to reference Kalman L, Lindegren ML, Kobrynsk L, Vogt R, Hannon H, Howard JT, et al. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genetics in Medicine. 2004;6(1):16–26.CrossRefPubMed Kalman L, Lindegren ML, Kobrynsk L, Vogt R, Hannon H, Howard JT, et al. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genetics in Medicine. 2004;6(1):16–26.CrossRefPubMed
8.
go back to reference Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary İmmunodeficiency Registry. Journal of Clinical Immunology. 2006;26:519–32.CrossRefPubMed Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary İmmunodeficiency Registry. Journal of Clinical Immunology. 2006;26:519–32.CrossRefPubMed
9.
go back to reference Al-Atatas RA, Rahi AH. Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. Journal of Clinical Immunology. 1998;18:368–71.CrossRef Al-Atatas RA, Rahi AH. Primary antibody deficiency in Arabs: first report from eastern Saudi Arabia. Journal of Clinical Immunology. 1998;18:368–71.CrossRef
10.
go back to reference Al-Herz W. Primary ımmunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004–2006). Journal of Clinical Immunology. 2008;28:186–93.CrossRefPubMed Al-Herz W. Primary ımmunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (20042006). Journal of Clinical Immunology. 2008;28:186–93.CrossRefPubMed
11.
go back to reference Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. Journal of Clinical Immunology. 1988;8:479–85.CrossRefPubMed Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. Journal of Clinical Immunology. 1988;8:479–85.CrossRefPubMed
12.
go back to reference Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. The Journal of Allergy and Clinical Immunology. 1997;100:415–23.CrossRefPubMed Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. The Journal of Allergy and Clinical Immunology. 1997;100:415–23.CrossRefPubMed
13.
go back to reference Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary ımmunodeficiency diseases in the Turk ethnic group, living in the Northwestern Iran. Journal of Clinical Immunology. 2007;27:5.CrossRef Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary ımmunodeficiency diseases in the Turk ethnic group, living in the Northwestern Iran. Journal of Clinical Immunology. 2007;27:5.CrossRef
14.
go back to reference Reda SM, Afifi HM, Amine MM. Primary ımmunodeficiency diseases in Egyptian children: a single-center study. Journal of Clinical Immunology. 2009;29:343–51.CrossRefPubMed Reda SM, Afifi HM, Amine MM. Primary ımmunodeficiency diseases in Egyptian children: a single-center study. Journal of Clinical Immunology. 2009;29:343–51.CrossRefPubMed
15.
go back to reference Aksu G, Kutukculer N, Genel F, Koturoglu G, Kurugol Z. Serum immunoglobulin (IgG, A, M) and IgG subclass concentrations in healthy children: a study using nephelometric technique. The Turkish Journal of Pediatrics. 2006;48:19–24.PubMed Aksu G, Kutukculer N, Genel F, Koturoglu G, Kurugol Z. Serum immunoglobulin (IgG, A, M) and IgG subclass concentrations in healthy children: a study using nephelometric technique. The Turkish Journal of Pediatrics. 2006;48:19–24.PubMed
16.
go back to reference Ikincioğulları A, Kendirli T, Doğu F. Peripheral blood lymphocyte subsets in healthy Turkish children. The Turkish Journal of Pediatrics. 2004;46:125–30.PubMed Ikincioğulları A, Kendirli T, Doğu F. Peripheral blood lymphocyte subsets in healthy Turkish children. The Turkish Journal of Pediatrics. 2004;46:125–30.PubMed
17.
go back to reference Yee A, De Ravin SS, Elliott E, Ziegler JB. Severe combined immunodeficiency: a national surveillance study. Pediatric Allergy and Immunology. 2008;19(4):298–302. doi:dx.doi.org.CrossRefPubMed Yee A, De Ravin SS, Elliott E, Ziegler JB. Severe combined immunodeficiency: a national surveillance study. Pediatric Allergy and Immunology. 2008;19(4):298–302. doi:dx.​doi.​org.CrossRefPubMed
18.
go back to reference Yorulmaz A, Artac H, Kara R, Keles S, Reisli I. Primer immün yetmezlikli 1054 olgunun retrospektif değerlendirilmesi. Astim Allerji Immunoloji. 2008;6:127–34. Yorulmaz A, Artac H, Kara R, Keles S, Reisli I. Primer immün yetmezlikli 1054 olgunun retrospektif değerlendirilmesi. Astim Allerji Immunoloji. 2008;6:127–34.
19.
go back to reference Villartay JP, Schwarz K, Villa A. V(D)J recombination defects. In: Ochs HD, Smith CIE, Puck J, editors. Primary immunodeficiency diseases, vol. 2. New York: Oxford University Press; 2007. p. 153–68. Villartay JP, Schwarz K, Villa A. V(D)J recombination defects. In: Ochs HD, Smith CIE, Puck J, editors. Primary immunodeficiency diseases, vol. 2. New York: Oxford University Press; 2007. p. 153–68.
20.
go back to reference Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 2007;105:177–86.CrossRef Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 2007;105:177–86.CrossRef
21.
go back to reference Karaca NE, Aksu G, Genel F, Gulez N, Can S, Aydınok Y, et al. Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID. Clinical and Experimental Medicine. 2009;9:339–42.CrossRefPubMed Karaca NE, Aksu G, Genel F, Gulez N, Can S, Aydınok Y, et al. Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID. Clinical and Experimental Medicine. 2009;9:339–42.CrossRefPubMed
22.
go back to reference Kato M, Kimura H, Seki M, Shimada A, Hayashi Y, Morio T, et al. Omenn syndrome—review of several phenotypes of Omenn syndrome and RAG1-RAG2 mutations in Japan. Allergology International. 2006;55:115–9.CrossRefPubMed Kato M, Kimura H, Seki M, Shimada A, Hayashi Y, Morio T, et al. Omenn syndrome—review of several phenotypes of Omenn syndrome and RAG1-RAG2 mutations in Japan. Allergology International. 2006;55:115–9.CrossRefPubMed
23.
go back to reference Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, et al. Clinical and laboratory findings in hyper- IgM syndrome with novel CD40L and AICDA mutations. Journal of Clinical Immunology. 2009;29:769–76.CrossRefPubMed Aghamohammadi A, Parvaneh N, Rezaei N, Moazzami K, Kashef S, Abolhassani H, et al. Clinical and laboratory findings in hyper- IgM syndrome with novel CD40L and AICDA mutations. Journal of Clinical Immunology. 2009;29:769–76.CrossRefPubMed
24.
go back to reference Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82:373–84.CrossRefPubMed Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82:373–84.CrossRefPubMed
25.
go back to reference Mazzolari E, Lanzi G, Forino C, Lanfranchi A, Aksu G, Ozturk C, et al. First report of successful stem cell transplantation in a child with CD40 deficiency. Bone Marrow Transplantation. 2007;40(3):279–81.CrossRefPubMed Mazzolari E, Lanzi G, Forino C, Lanfranchi A, Aksu G, Ozturk C, et al. First report of successful stem cell transplantation in a child with CD40 deficiency. Bone Marrow Transplantation. 2007;40(3):279–81.CrossRefPubMed
Metadata
Title
Consanguinity Rate and Delay in Diagnosis in Turkish Patients with Combined Immunodeficiencies: a Single-Center Study
Authors
Elif Azarsiz
Nesrin Gulez
Neslihan Edeer Karaca
Guzide Aksu
Necil Kutukculer
Publication date
01-02-2011
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2011
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-010-9472-8

Other articles of this Issue 1/2011

Journal of Clinical Immunology 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.